Genertec Universal Medical Group Co Ltd
HKEX:2666
Intrinsic Value
Genertec Universal Medical Group Co., Ltd. engages in the provision of healthcare services. [ Read More ]
The intrinsic value of one
Genertec Universal Medical Group Co Ltd
stock under the Base Case scenario is
24.6
HKD.
Compared to the current market price of 4.57 HKD,
Genertec Universal Medical Group Co Ltd
is
Undervalued by 81%.
Genertec Universal Medical Group Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Genertec Universal Medical Group Co Ltd's market capitalization is 8.6B HKD.
Genertec Universal Medical Group Co Ltd stock price is 4.57 HKD.
Genertec Universal Medical Group Co Ltd stock price (4.57 HKD) is 81% less than its Intrinsic Value (24.6 HKD).
Genertec Universal Medical Group Co Ltd stock price (4.57 HKD) is 83% less than its DCF Value (27.6 HKD). Open DCF Valuation
Genertec Universal Medical Group Co Ltd stock price (4.57 HKD) is 79% less than its Relative Value (21.6 HKD). Open Relative Valuation
Genertec Universal Medical Group Co Ltd has upside potential of 58% compared to the average analyst price target.
Open Wall St Estimates
Genertec Universal Medical Group Co Ltd's short-term assets (31B CNY) exceed its short-term liabilties (30B CNY).
Genertec Universal Medical Group Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 4% to 3%.
Genertec Universal Medical Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 12%.
Genertec Universal Medical Group Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 14% to 12%.
Genertec Universal Medical Group Co Ltd's Revenue has grown by 13% over the past 12 months.
Genertec Universal Medical Group Co Ltd has positive three-year average ROE (Return on Equity): 13%. The company is efficient at transforming stockholders' equity into net income.
Genertec Universal Medical Group Co Ltd's long-term assets (80B CNY) exceed its long-term liabilties (63B CNY).
Genertec Universal Medical Group Co Ltd has positive Net Income for the last twelve months.
Genertec Universal Medical Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
Genertec Universal Medical Group Co Ltd's Revenue has been growing by 17% per year for the last 3 years.
Genertec Universal Medical Group Co Ltd has positive Operating Income for the last twelve months.
Genertec Universal Medical Group Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 3%. The company is not efficient at using invested capital to generate operating income.
Genertec Universal Medical Group Co Ltd's D/E (Debt to Equity) is equal to 1.83.
Genertec Universal Medical Group Co Ltd has positive Gross Profit for the last twelve months.
Genertec Universal Medical Group Co Ltd has positive Free Cash Flow for the last twelve months.
Genertec Universal Medical Group Co Ltd has positive Net Debt. This means that the company has more debt (32B CNY) than cash and short-term investments (3B CNY).
Genertec Universal Medical Group Co Ltd's Altman Z-Score is very low and is equal to 0.6.
Genertec Universal Medical Group Co Ltd generates enough operating income (3B CNY) to cover interest payments on its debt (2B CNY).
Valuation Backtest
Genertec Universal Medical Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Genertec Universal Medical Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Genertec Universal Medical Group Co Ltd
Balance Sheet Decomposition
Genertec Universal Medical Group Co Ltd
| Current Assets | 30.7B |
| Cash & Short-Term Investments | 2.9B |
| Receivables | 25.7B |
| Other Current Assets | 2.1B |
| Non-Current Assets | 49.6B |
| Long-Term Investments | 777.7m |
| PP&E | 5.6B |
| Intangibles | 447.8m |
| Other Non-Current Assets | 42.9B |
| Current Liabilities | 30.1B |
| Accounts Payable | 3B |
| Short-Term Debt | 6.6B |
| Other Current Liabilities | 20.5B |
| Non-Current Liabilities | 32.9B |
| Long-Term Debt | 25.1B |
| Other Non-Current Liabilities | 7.8B |
Earnings Waterfall
Genertec Universal Medical Group Co Ltd
|
Revenue
|
13.7B
CNY
|
|
Cost of Revenue
|
-9.1B
CNY
|
|
Gross Profit
|
4.6B
CNY
|
|
Operating Expenses
|
-2B
CNY
|
|
Operating Income
|
2.6B
CNY
|
|
Other Expenses
|
-590.3m
CNY
|
|
Net Income
|
2B
CNY
|
Free Cash Flow Analysis
Genertec Universal Medical Group Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Genertec Universal Medical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Genertec Universal Medical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Genertec Universal Medical Group Co Ltd's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Score
Genertec Universal Medical Group Co Ltd's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Genertec Universal Medical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Genertec Universal Medical Group Co Ltd
is 7.21 HKD
with a low forecast of 5.25 HKD and a high forecast of 9.45 HKD.
Shareholder Return
Price
Genertec Universal Medical Group Co Ltd
| Average Annual Return | -2.5% |
| Standard Deviation of Annual Returns | 6.29% |
| Max Drawdown | -55% |
| Market Capitalization | 8.6B HKD |
| Shares Outstanding | 1 891 539 660 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Genertec Universal Medical Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Genertec Universal Medical Group Co., Ltd. engages in the provision of healthcare services. The company is headquartered in Beijing, Beijing and currently employs 15,242 full-time employees. The company went IPO on 2015-07-08. The firm mainly operates through two segments. The Finance and Advisory Business segment mainly includes direct finance leasing, sale and leaseback, factoring, operating leases and advisory services. The Hospital Group Business segment mainly includes comprehensive medical services, hospital operation management, and import and export trade and domestic trade of medical-related goods. The firm mainly conducts business in China.
Contact
IPO
Employees
Officers
The intrinsic value of one
Genertec Universal Medical Group Co Ltd
stock under the Base Case scenario is
24.6
HKD.
Compared to the current market price of 4.57 HKD,
Genertec Universal Medical Group Co Ltd
is
Undervalued by 81%.
You don't have any saved screeners yet
